Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-21-001909
Date:2021-03-01
Issuer: SYNDAX PHARMACEUTICALS INC (SNDX)
Original Submission Date:

Reporting Person:

EGROS FABRICE
C/O SYNDAX PHARMACEUTICALS, INC.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3 WALTHAM, MA 02451

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-03-01 M 10,167 a $6.35 26,167 direct
COMMON STOCK 2021-03-01 M 74 a $7.20 26,241 direct
COMMON STOCK 2021-03-01 S 10,167 d $24.31 16,074 direct
COMMON STOCK 2021-03-01 S 74 d $24.31 16,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 7.2 2021-03-01 deemed execution date M 74 (d) 2025-08-18 common stock 0 $7.20 0 direct
STOCK OPTIONS (RIGHT TO BUY) 6.35 2021-03-01 deemed execution date M 10,167 (d) 2024-12-18 common stock 0 $6.35 0 direct
Footnotes
IDfootnote
f1 the sale reported in this form 4 was effected pursuant to a rule 10b5-1 plan adopted by the reporting person. following the sale reported in this form 4, the reporting person has a total of 106,926 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested.
f2 the sale prices ranged from $23.84 to $25.15.
f3 this option is fully vested.
WhaleWisdom Logo

Elevate your investments